theMednet - What is your preferred third-line therapy for a fit patient with symptomatic, relapsed follicular lymphoma who has failed bendamustine-rituximab and lenalidomide-rituximab?

Topics: Hematologic Malignancies • Medical Oncology • Lymphoma • NCI-CCC Tumor Board Question • Hematology • NCI-CCC Lymphoma Tumor Board Question • City of Hope

What is your preferred third-line therapy for a fit patient with symptomatic, relapsed follicular lymphoma who has failed bendamustine-rituximab and lenalidomide-rituximab?